USD 0.01
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 129.29 Thousand USD | 86.76% |
2022 | 69.23 Thousand USD | -24.76% |
2021 | 92.01 Thousand USD | -48.35% |
2020 | 178.16 Thousand USD | 253.36% |
2019 | 50.41 Thousand USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 162.92 Thousand USD | 9.84% |
2024 Q1 | 148.32 Thousand USD | 14.72% |
2023 Q4 | 129.29 Thousand USD | 8.25% |
2023 FY | 129.29 Thousand USD | 86.76% |
2023 Q3 | 119.44 Thousand USD | 5.81% |
2023 Q2 | 112.88 Thousand USD | 23.19% |
2023 Q1 | 91.62 Thousand USD | 32.35% |
2022 Q3 | 63.09 Thousand USD | 0.0% |
2022 Q4 | 69.23 Thousand USD | 9.73% |
2022 FY | 69.23 Thousand USD | -24.76% |
2021 FY | 92.01 Thousand USD | -48.35% |
2020 FY | 178.16 Thousand USD | 253.36% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
American Bio Medica Corporation | 3.6 Million USD | 96.416% |
Arrayit Corporation | 7.49 Million USD | 98.275% |
Atlantic International Corp. | 3.82 Million USD | 96.623% |
Biocept, Inc. | 22.01 Million USD | 99.413% |
Bioqual, Inc. | 18.93 Million USD | 99.317% |
CardioGenics Holdings Inc | 1.79 Million USD | 92.797% |
DermTech, Inc. | 64.75 Million USD | 99.8% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | 99.982% |
HTG Molecular Diagnostics, Inc. | 12.38 Million USD | 98.956% |
iMD Companies, Inc. | 1.67 Million USD | 92.277% |
IDenta Corp. | 1.01 Million USD | 87.238% |
Interpace Biosciences, Inc. | 28.15 Million USD | 99.541% |
Integrative Health Technologies, Inc. | 297.94 Thousand USD | 56.604% |
InVitro International | 78.99 Thousand USD | -63.688% |
Lumos Diagnostics Holdings Limited | 19.72 Million USD | 99.345% |
Medical Imaging Corp. | 9.51 Million USD | 98.641% |
NovelStem International Corp. | 4.2 Million USD | 96.926% |
Optigenex Inc. | 9.57 Million USD | 98.649% |
PharmChem, Inc. | 558.64 Thousand USD | 76.855% |
Proteome Sciences plc | 18.48 Million USD | 99.301% |
Response Genetics, Inc | 15.86 Million USD | 99.185% |
Rennova Health, Inc. | 49.66 Million USD | 99.74% |
RushNet, Inc. | 6.23 Million USD | 97.928% |
ScreenPro Security Inc. | 1.6 Million USD | 91.922% |
Stella Diagnostics Inc. | 18 Million USD | 99.282% |
StageZero Life Sciences Ltd. | 8.2 Million USD | 98.424% |
Todos Medical Ltd. | 50.15 Million USD | 99.742% |